Bangladesh Pharmaceuticals and Healthcare Report Q1 2015

BMI Research
December 17, 2014
112 Pages - SKU: BMI5416293
Countries covered: Bangladesh

Bangladesh Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Chronic diseases will become a key healthcare challenge for Bangladesh over the next decade.

Driven by the country's ageing population, urbanisation and inadequate treatment of non-communicablediseases, this represents an epidemiological transition that will present new opportunities forpharmaceutical companies.

Headline Expenditure Projections

Pharmaceuticals: BDT138.81bn (USD1.78bn) in 2013 to BDT154.62bn (USD1.99bn) in 2014; +11.4%in local currency terms and +11.9% in US dollar terms

Healthcare: BDT376.11bn (USD4.82bn) in 2013 to BDT421.33bn (USD5.42bn) in 2014; +12.0% inlocal currency terms and +12.6% in US dollar terms



More Prescription Drugs reports by BMI Research

Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Zimbabwe Pharmaceuticals and Healthcare Report Q2 2015BMI View: Zimbabwe's Treasury has failed to assign sufficient funds to the health sector in its 2015 National Budget, ...
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
United Kingdom Pharmaceuticals and Healthcare Report Q2 2015BMI View: The ageing population will have an unprecedented impact on the demand of healthcare and therapeutics in ...
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q2 2015BMI View: Access to healthcare in Sudan and South Sudan is poor and drug shortages are ...
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015 by BMI Research
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2015BMI View: Sri Lanka's strong pharmaceutical market is backed by a committed government and plans to deliver improved ...
See all reports like this >>

More Bangladesh Prescription Drugs reports

Pharmaceuticals and Healthcare : Bangladesh Pharmaceuticals and Healthcare Report Q3 2014 by BMI Research
Pharmaceuticals and Healthcare : Bangladesh Pharmaceuticals and Healthcare Report Q3 2014BMI View: It is vital that Bangladesh's government works to improve the business environment for ...
Antibiotics Market in Bangladesh to 2016 by Global Research & Data Services Oy
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Bangladesh. The study provides essential market ...
The Pharmaceutical Market: Bangladesh by Espicom Healthcare Intelligence
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of ...
The Pharmaceutical Market: Bangladesh (pdf/xls) by Espicom Healthcare Intelligence
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!